Thompson RH - Search Results

1

Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death.

Parasramka M, Serie DJ, Asmann YW, Eckel-Passow JE, Castle EP, Stanton ML, Leibovich BC, Thompson RH, Thompson EA, Parker AS, Ho TH, Joseph RW. Parasramka M, et al. Among authors: thompson ea, thompson rh. Eur Urol Focus. 2016 Dec 15;2(6):608-615. doi: 10.1016/j.euf.2016.03.008. Epub 2016 Apr 2. Eur Urol Focus. 2016. PMID: 28723492

2

Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?

Leibovich BC, Cheville JC, Lohse CM, Zincke H, Kwon ED, Frank I, Thompson RH, Blute ML. Leibovich BC, et al. Among authors: thompson rh. J Urol. 2005 Mar;173(3):716-9. doi: 10.1097/01.ju.0000151830.27750.d2. J Urol. 2005. PMID: 15711250

3

Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?

Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Frank I, Kwon ED, Zincke H, Blute ML. Thompson RH, et al. J Urol. 2005 Mar;173(3):918-21. doi: 10.1097/01.ju.0000153419.98715.24. J Urol. 2005. PMID: 15711327

4

Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma?

Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED, Frank I, Zincke H, Blute ML. Thompson RH, et al. J Urol. 2005 Oct;174(4 Pt 1):1218-21. doi: 10.1097/01.ju.0000173942.19990.40. J Urol. 2005. PMID: 16145373

5

B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma.

Thompson RH, Webster WS, Cheville JC, Lohse CM, Dong H, Leibovich BC, Kuntz SM, Sengupta S, Kwon ED, Blute ML. Thompson RH, et al. Urology. 2005 Nov;66(5 Suppl):10-4. doi: 10.1016/j.urology.2005.06.010. Urology. 2005. PMID: 16194701

6

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, Sengupta S, Frank I, Parker AS, Zincke H, Blute ML, Sebo TJ, Cheville JC, Kwon ED. Thompson RH, et al. Cancer Res. 2006 Apr 1;66(7):3381-5. doi: 10.1158/0008-5472.CAN-05-4303. Cancer Res. 2006. PMID: 16585157

7

Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score.

Thompson RH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML, Frank I. Thompson RH, et al. J Urol. 2007 Feb;177(2):477-80. doi: 10.1016/j.juro.2006.09.057. J Urol. 2007. PMID: 17222614

8

Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.

Krambeck AE, Dong H, Thompson RH, Kuntz SM, Lohse CM, Leibovich BC, Blute ML, Sebo TJ, Cheville JC, Parker AS, Kwon ED. Krambeck AE, et al. Among authors: thompson rh. Clin Cancer Res. 2007 Mar 15;13(6):1749-56. doi: 10.1158/1078-0432.CCR-06-2129. Clin Cancer Res. 2007. PMID: 17363528

9

Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma.

Webster WS, Thompson RH, Cheville JC, Lohse CM, Blute ML, Leibovich BC. Webster WS, et al. Among authors: thompson rh. Urology. 2007 Nov;70(5):900-4; discussion 904. doi: 10.1016/j.urology.2007.05.029. Urology. 2007. PMID: 18068445

10

Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.

Thompson RH, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML. Thompson RH, et al. Urology. 2008 Apr;71(4):713-7. doi: 10.1016/j.urology.2007.11.018. Epub 2008 Feb 11. Urology. 2008. PMID: 18267338

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

764 results

Search Page

Filters